Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

by NASDAQ Market News January 28, 2020

NASDAQ Market News
Click here to email author

Snow Companies Launches New Tool for Finding Branded Social Media Pages

Global infectious disease diagnostic market is expected to grow with a CAGR of 8.7% over the forecast period from 2019-2025

Ads